Literature DB >> 31032312

Strengthening the foundation of kidney cancer treatment and research: revising the AJCC staging system.

Hiren V Patel1, Arnav Srivastava1, Brian Shinder1, Evita Sadimin2, Eric A Singer1.   

Abstract

Entities:  

Year:  2019        PMID： 31032312      PMCID： PMC6462582          DOI： 10.21037/atm.2019.02.19

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  4 in total

1.  Dissecting the role of lymphadenectomy in the management of renal cell carcinoma: past, present, and future.

Authors:  Alain Kaldany; Zev R Leopold; Juliana E Kim; Hiren V Patel; Arnav Srivastava; Alexandra L Tabakin; Eric A Singer
Journal:  Kidney Cancer J       Date:  2020-12

Review 2.  A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer.

Authors:  Daniel M Geynisman; Jodi K Maranchie; Mark W Ball; Gennady Bratslavsky; Eric A Singer
Journal:  Urol Oncol       Date:  2021-06-04       Impact factor: 2.954

3.  Reassessment of American Joint Committee on Cancer Staging for Stage III Renal Cell Carcinoma With Nodal Involvement: Propensity Score Matched Analyses of a Large Population-Based Study.

Authors:  Jianglong Han; Qin Li; Ping Li; Shijie Wang; Rui Zhang; Yunfeng Qiao; Qibin Song; Zhenming Fu
Journal:  Front Oncol       Date:  2020-03-19       Impact factor: 6.244

4.  circPRRC2A promotes angiogenesis and metastasis through epithelial-mesenchymal transition and upregulates TRPM3 in renal cell carcinoma.

Authors:  Wei Li; Feng-Qiang Yang; Chen-Min Sun; Jian-Hua Huang; Hai-Min Zhang; Xue Li; Guang-Chun Wang; Ning Zhang; Jian-Ping Che; Wen-Tao Zhang; Yang Yan; Xu-Dong Yao; Bo Peng; Jun-Hua Zheng; Min Liu
Journal:  Theranostics       Date:  2020-03-15       Impact factor: 11.556
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.